Krishana Phoschem Limited has informed the Exchange regarding 'Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Result Presentation of the Company for the quarter ended June 30, 2025 '.
KRISHANA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Krishana Phoschem reported strong Q1 FY26 results, with revenue rising 40.8% YoY to ₹395.5 Cr and PAT jumping 86.6% YoY to ₹30.6 Cr. EBITDA grew 56.6% YoY to ₹65.6 Cr, with EBITDA margin expanding to 16.6% from 14.9% in Q1 FY25, and PAT margin improving to 7.8% from 5.8%. The company achieved record-high quarterly operating earnings, driven by strong demand, capacity utilization of 81% for NPK/DAP and 92% for SSP, and disciplined cost control. However, revenue and PAT declined sequentially (QoQ) by around 16%. The company is undertaking a ₹142 Cr capacity expansion at Meghnagar (165,000 MTPA NPK/DAP and 99,000 MTPA Sulphuric Acid), targeted for commissioning by March 2026, and launched two new products — Bharat Urea SSP and Annadata Super 6.
Strong YoY growth and margin expansion signal healthy operating leverage, though the QoQ decline may raise near-term concerns. The ongoing capacity expansion and new product launches position the company for sustained growth, potentially supporting a positive stock reaction given the sharp earnings beat.